Compare Amgen, Inc. (AMGN) vs ING Groep NV (ING) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Amgen, Inc. vs ING Groep NV — how do they compare? Amgen, Inc. trades at $412.77 (market cap $224.14B), while ING Groep NV trades at $35.49 (market cap $101.22B). The key difference: Amgen, Inc. is far larger — about 2.2× ING Groep NV's market cap, and ING Groep NV pays the higher dividend (3.73%). Which is the better fit depends on your goals.
| AMGN | ING | |
|---|---|---|
Market Cap | $224.14B | $101.22B |
Sector | Health | Financials |
52-Week High | $417.20 | $35.92 |
52-Week Low | $271.18 | $23.66 |
Enterprise Value | $267.45B | — |
Dividend Yield | 2.43% | 3.73% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Amgen, Inc.
Amgen is a leader in biotechnology-based human therapeutics, with historical expertise in renal disease and cancer supportive-care products. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and markets bone-strengthening drug Prolia/Xgeva (approved 2010) and Evenity (2019). The acquisition of Onyx bolstered the firm's therapeutic oncology portfolio with Kyprolis. Recent launches include Repatha (cholesterol-lowering), Aimovig (migraine), Lumakras (lung cancer), and Tezspire (asthma). Amgen's biosimilar portfolio includes Mvasi (biosimilar Avastin), Kanjinti (biosimilar Herceptin), and Amgevita (biosimilar Humira).
Read more on AMGN →About ING Groep NV
The merger of the Dutch postal bank and NN Insurance in 1991 created ING. Through a series of further acquisitions ING build up a global footprint. The 2008 financial crisis forced ING to seek government support--a precondition of which was that ING should separate its banking and insurance activities, which saw ING revert to being solely a bank. ING has market- leading banking operations in the Netherlands and Belgium, and a range of digital banks across Europe and Australia. Its global wholesale banking operation is primarily focused on lending.
Read more on ING →
